Search
for

    Sort by

    Research 30 of 1000+

    1. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    2. Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial Prostate International · 2023 · 1 citations
    3. Acute urinary retention: risks and management. PubMed · 2005 · 46 citations
    4. Intervention beim PCa: leichte Pluspunkte für radikale Prostatektomie Uro-News · 2012
    5. Glatze in jungen Jahren könnte Risikofaktor für BPH sein Uro-News · 2012
    6. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    7. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    8. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature Archivio Italiano di Urologia e Andrologia · 2020 · 14 citations
    9. Doxazosin and finasteride alone or in combination: the PREDICT study BJUI · 2003 · 3 citations
    10. Androgenetic alopecia as an early marker of benign prostatic hyperplasia Journal of The American Academy of Dermatology · 2011 · 28 citations
    11. 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY The Journal of Urology · 2010
    12. The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1998 · 1054 citations
    13. UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood Urology · 2011
    14. A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly l-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from BJUI · 2001 · 30 citations
    15. UP-02.008 Patients' Characteristics and Urodynamic Parameters of Pressure-Flow Study Failure of Patients in Our Institution Urology · 2011
    16. Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial African Journal of Urology · 2024 · 1 citations
    17. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    18. Comparison of Different Alpha-blocker Combinations in Male Hypertensives with Refractory Lower Urinary Tract Symptoms Korean Journal of Andrology · 2011 · 8 citations
    19. Efficacy and Safety of Thermobalancing Therapy in Men with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia was Confirmed by Clinical Trial ARC Journal of Urology · 2016 · 1 citations
    20. Efficacy of Combination of Tamsulosin and Finasteride on Urinary Symptoms and IPSS Score for Elderly Patients with BPH Hebei yixue · 2014
    21. 5α-reductase inhibitors/finasteride The Prostate · 1996 · 24 citations
    22. 5alpha-reductase inhibitors/finasteride. PubMed · 1996 · 4 citations
    23. 1747 PREDICTION OF BLADDER PROSTATIC OBSTRUCTION: DEVELOPMENT OF A SIMPLIFIED CLINICAL NOMOGRAM The Journal of Urology · 2013
    24. Saw Palmetto Humana Press eBooks · 2007
    25. Efficacy and safety of long-term administration of tamsulosin hydrochloride in patients with LUTS suggestive of BPH Zhonghua miniao waike zazhi · 2010
    26. Meta-Analysis of Randomized Clinical Trials of Finasteride Urology · 1998 · 21 citations
    27. Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years European Urology · 1998 · 34 citations
    28. Finasteride Drugs · 1999 · 40 citations
    29. 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia Actas urológicas españolas · 2018
    30. Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis European journal of medical research · 2026